Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Bower

Showing results (141-150 of 252) with videos related to

Pageof 26
Sort By:
AIDS (London, England)|August 11, 2007
Virological failure and subsequent resistance profiles in individuals exposed to atazanavirJustin Stebbing, Bif Nathan, Rachael Jones, et al.
AIDS (London, England)|December 4, 2004
Simplified one-step antibody-HLA directed expansion of HIV-specific cytotoxic T lymphocytes: a system suited for use in vivoJustin Stebbing, Brian Gazzard, Steve Patterson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2008
Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infectionThomas Powles, David Robinson, Justin Stebbing, et al.
AIDS (London, England)|February 28, 2008
A long-term durable remission with high-dose therapy and autologous stem cell transplant for stage IVB HIV-associated Hodgkins diseaseIan Gabriel, Jane Apperley, Mark Bower, et al.
AIDS (London, England)|September 10, 2003
Natural killer cells are not infected by Kaposi's sarcoma-associated herpesvirus in vivo, and natural killer cell counts do not correlate with the risk of developing Kaposi's sarcomaJustin Stebbing, Brian Gazzard, Ornella Flore, et al.
AIDS (London, England)|August 24, 2010
A double-blind, randomized controlled trial of the use of imiquimod cream for the treatment of anal canal high-grade anal intraepithelial neoplasia in HIV-positive MSM on HAART, with long-term follow-up data including the use of open-label imiquimodPaul A Fox, Mayura Nathan, Nicholas Francis, et al.
European Journal of Cancer (Oxford, England : 1990)|July 23, 2011
Colorectal cancer in HIV positive individuals: the immunological effects of treatmentMaryam Alfa-Wali, Diana Tait, Tim Allen-Mersh, et al.
BMC Urology|September 2, 2009
HIV-associated bladder cancer: a case series evaluating difficulties in diagnosis and managementElizabeth M Gaughan, Bruce J Dezube, Mark Bower, et al.
International Journal of Cancer|December 23, 2016
Eurogin 2016 Roadmap: how HPV knowledge is changing screening practiceNicolas Wentzensen, Marc Arbyn, Johannes Berkhof, et al.
The Lancet. Oncology|March 29, 2023
From the European Medicines Agency to Project Orbis: new activities and challenges to facilitate UK oncology drug approval following BrexitMark P Lythgoe, Jonathan Krell, Mark Bower, et al.
Pageof 26

Showing results (141-150 of 252) with videos related to

Sort By:
Pageof 26
AIDS (London, England)|August 11, 2007
Virological failure and subsequent resistance profiles in individuals exposed to atazanavirJustin Stebbing, Bif Nathan, Rachael Jones, et al.
AIDS (London, England)|December 4, 2004
Simplified one-step antibody-HLA directed expansion of HIV-specific cytotoxic T lymphocytes: a system suited for use in vivoJustin Stebbing, Brian Gazzard, Steve Patterson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2008
Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infectionThomas Powles, David Robinson, Justin Stebbing, et al.
AIDS (London, England)|February 28, 2008
A long-term durable remission with high-dose therapy and autologous stem cell transplant for stage IVB HIV-associated Hodgkins diseaseIan Gabriel, Jane Apperley, Mark Bower, et al.
AIDS (London, England)|September 10, 2003
Natural killer cells are not infected by Kaposi's sarcoma-associated herpesvirus in vivo, and natural killer cell counts do not correlate with the risk of developing Kaposi's sarcomaJustin Stebbing, Brian Gazzard, Ornella Flore, et al.
AIDS (London, England)|August 24, 2010
A double-blind, randomized controlled trial of the use of imiquimod cream for the treatment of anal canal high-grade anal intraepithelial neoplasia in HIV-positive MSM on HAART, with long-term follow-up data including the use of open-label imiquimodPaul A Fox, Mayura Nathan, Nicholas Francis, et al.
European Journal of Cancer (Oxford, England : 1990)|July 23, 2011
Colorectal cancer in HIV positive individuals: the immunological effects of treatmentMaryam Alfa-Wali, Diana Tait, Tim Allen-Mersh, et al.
BMC Urology|September 2, 2009
HIV-associated bladder cancer: a case series evaluating difficulties in diagnosis and managementElizabeth M Gaughan, Bruce J Dezube, Mark Bower, et al.
International Journal of Cancer|December 23, 2016
Eurogin 2016 Roadmap: how HPV knowledge is changing screening practiceNicolas Wentzensen, Marc Arbyn, Johannes Berkhof, et al.
The Lancet. Oncology|March 29, 2023
From the European Medicines Agency to Project Orbis: new activities and challenges to facilitate UK oncology drug approval following BrexitMark P Lythgoe, Jonathan Krell, Mark Bower, et al.
Pageof 26